Acalabrutinib/Obinutuzumab/Venetoclax Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of acalabrutinib, obinutuzumab and venetoclax that can be used for the treatment of chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).

**Synonyms:** - Acalabrutinib-Obinutuzumab-Venetoclax - Acalabrutinib/Obinutuzumab/Venetoclax - Acalabrutinib/Venetoclax/Obinutuzumab - Calquence/Gazyva/Venclexta Regimen - Obinutuzumab/Acalabrutinib/Venetoclax - Obinutuzumab/Venetoclax/Acalabrutinib - Venclexta/Calquence/Gazyva - Venetoclax/Acalabrutinib/Obinutuzumab - Venetoclax/Obinutuzumab/Acalabrutinib